University of Maryland School of Medicine, CIVICs Clinical Core

About

The University of Maryland School of Medicine, CIVICs Clinical Core draws on more than four decades of innovative and groundbreaking research on the development, evaluation, and deployment of vaccines at the Center for Vaccine Development and Global Health (CVD). The Clinical Core embraces a cohesive, collaborative approach to advancing the development of novel influenza vaccines. The accomplished, multidisciplinary team brings extensive clinical research and regulatory experience, including the design and performance of clinical trials in all phases of development and diverse populations, and the design and execution of human challenge studies. Using in-depth influenza vaccine and immunology expertise and efficient project management, investigators advance scientific understanding of human immunity and support the development of improved influenza vaccines in state of the art clinical and laboratory facilities. The reach of the Clinical Core and its capacities are extended through strong partnerships with collaborating institutions at Vanderbilt University and The State University of New York (SUNY), Upstate.

Principal Investigator

PROFESSOR, MEDICINE AND PEDIATRICS

The Myron M. Levine, MD Professorship in Vaccinology

Director, Center for Vaccine Development and Global Health, University of Maryland School of Medicine

Investigators

University of Maryland, Baltimore

The State University of New York (SUNY)

Vanderbilt University

Other Key Personnel

Chief Business Officer

  • Henry Seifert, MPH, Chief Business Officer, Center for Vaccine Development and Global Health

Program Manager

  • Terry Sharp, Director, Grants and Contracts, Center for Vaccine Development and Global Health

Program Coordinator

  • Mallory White, Grants and Contracts Specialist, Center for Vaccine Development and Global Health

Clinical Research Manager

  • Lisa Chrisley, RN, Nurse Coordinator, Center for Vaccine Development and Global Health

Quality Assurance Specialist

  • Brenda Dorsey, RN, MS, CCRP, Clinical Regulatory Specialist, Center for Vaccine Development and Global Health

Regulatory Specialist

  • Alyson (Aly) Kwon, MS, CCRC, Regulatory Affairs Specialist, Center for Vaccine Development and Global Health

Lab Manager

  • Mardi Reymann, Laboratory Research Manager, Center for Vaccine Development and Global Health

Program Specialist

  • Diane Egorugwu, MPH, Senior Program Specialist, Center for Vaccine Development and Global Health

Dr. James Campbell, Professor of Pediatrics, is one of the many investigators with the UMB Clinical Core team who bring their expertise to the development of a universal influenza vaccine.

Jim Campbell and patient